Comprehensive medication guide to Esomeprazole/Naproxen including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$10–$60+ copay with commercial insurance after prior authorization; typically placed at Tier 3–4 on formularies; Medicare Part D coverage varies by plan with a 2026 annual out-of-pocket cap of $2,100.
Estimated Cash Pricing
$2,300+ retail list price without discount; as low as $119–$130 for 60 tablets (30-day supply) with GoodRx or SingleCare coupons at participating pharmacies.
Medfinder Findability Score
62/100
On this page
Esomeprazole/naproxen, previously sold under the brand name Vimovo, is an FDA-approved prescription combination medication containing two active ingredients: naproxen, a nonsteroidal anti-inflammatory drug (NSAID) that reduces arthritis pain and inflammation, and esomeprazole, a proton pump inhibitor (PPI) that reduces stomach acid and protects the stomach lining from ulcers caused by naproxen therapy.
First approved by the FDA in 2010, esomeprazole/naproxen is indicated for adults and adolescents (≥12 years, ≥38 kg) with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, or juvenile idiopathic arthritis who require long-term NSAID therapy but are at elevated risk for developing NSAID-associated gastric ulcers. The brand-name Vimovo has been discontinued; FDA-approved generic versions are available from manufacturers including Ajanta Pharma USA and Dr. Reddy's Laboratories.
The combination tablet uses a sequential-release design: esomeprazole is released immediately to suppress stomach acid first, followed by delayed-release naproxen absorbed safely in the intestine. This pharmacokinetic sequencing cannot be replicated by taking naproxen and esomeprazole as two separate pills taken simultaneously.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Naproxen works by inhibiting both COX-1 and COX-2 cyclooxygenase enzymes, which are responsible for producing prostaglandins—the chemical mediators that drive inflammation, pain, and fever in arthritic joints. By blocking prostaglandin synthesis, naproxen reduces joint swelling, stiffness, and pain. However, COX-1 inhibition also reduces the stomach-protecting prostaglandins that maintain the gastric mucosal barrier, increasing the risk of ulcers.
Esomeprazole is a proton pump inhibitor (PPI) that irreversibly blocks the H+/K+ ATPase enzyme system in gastric parietal cells—the "proton pump" responsible for secreting hydrochloric acid into the stomach. By permanently inactivating this pump, esomeprazole dramatically reduces gastric acid levels, protecting the stomach lining from ulcer formation.
In the combination tablet, esomeprazole (immediate-release outer layer) is absorbed first, rapidly suppressing acid production. The enteric-coated naproxen core is then released in the intestine—after the stomach is already protected—and absorbed systemically to provide anti-inflammatory and analgesic effects. This is why the tablet must not be crushed, split, or chewed, and must be taken at least 30 minutes before meals.
375 mg/20 mg — delayed-release tablet
Naproxen 375 mg / Esomeprazole 20 mg — for adults or adolescents weighing 38–50 kg; take one tablet twice daily, at least 30 minutes before meals
500 mg/20 mg — delayed-release tablet
Naproxen 500 mg / Esomeprazole 20 mg — most common adult dose; take one tablet twice daily, at least 30 minutes before meals
Esomeprazole/naproxen is not on the FDA's Drug Shortage Database as of 2026, but many patients encounter significant difficulty filling their prescriptions. The brand-name Vimovo has been discontinued by its manufacturer, and generic versions from Ajanta Pharma and Dr. Reddy's are not stocked routinely at all pharmacies. This creates a pharmacy-level availability problem that is most pronounced at smaller or rural pharmacy locations.
High-volume chain pharmacies at urban or suburban locations are the most likely to carry generic esomeprazole/naproxen in stock. Mail-order pharmacies through insurance PBMs (Express Scripts, OptumRx, CVS Caremark) typically maintain more reliable inventory for specialty combination medications. Any pharmacy can also place a special order with a lead time of 1–3 business days.
Rather than calling multiple pharmacies yourself, you can use medfinder to contact pharmacies near you and find out which ones can fill your prescription—results are sent to you by text.
Esomeprazole/naproxen is not a controlled substance and carries no special DEA prescribing requirements. Any licensed prescriber in the United States with authority to write prescriptions can prescribe esomeprazole/naproxen. Prescriptions can be transmitted electronically, called in, or written on a standard prescription pad without any additional scheduling requirements.
Prescribers who commonly prescribe esomeprazole/naproxen include:
Telehealth prescribing is available for established arthritis patients in most states, as esomeprazole/naproxen is not a controlled substance. Most telehealth providers prefer an initial in-person evaluation before initiating long-term NSAID therapy due to the cardiovascular and GI risk assessment required.
No. Esomeprazole/naproxen is not a controlled substance and has no DEA drug schedule. Neither naproxen (an NSAID) nor esomeprazole (a PPI) has any abuse potential or dependency concerns that would qualify them for scheduling under the Controlled Substances Act.
Because esomeprazole/naproxen is not scheduled, any licensed prescriber can prescribe it without DEA registration for controlled substances. Refills can be called in electronically or by phone without the restrictions that apply to Schedule II–V medications. There are no federally mandated quantity limits. However, individual insurance plans may impose quantity limits as a formulary management tool.
Common side effects (occurring in 1–38% of patients):
Serious side effects requiring immediate medical attention:
Know what you need? Skip the search.
Celecoxib (Celebrex)
COX-2 selective NSAID with better GI tolerability; widely available as an inexpensive generic; does not require a separate PPI for most patients; preferred for GI-risk patients with acceptable cardiovascular risk
Diclofenac/Misoprostol (Arthrotec)
Fixed-dose NSAID + misoprostol (prostaglandin) combination; similar gastroprotective indication; note GI side effects from misoprostol and pregnancy contraindication
Ibuprofen/Famotidine (Duexis)
Fixed-dose NSAID (ibuprofen) + H2 blocker (famotidine) combination; taken three times daily; provides moderate GI protection; brand-name product
Meloxicam (Mobic)
Preferential COX-2 NSAID with better GI tolerability than non-selective NSAIDs; very inexpensive generic; once daily; widely stocked at all pharmacies; may be combined with OTC omeprazole for high-GI-risk patients
Prefer Esomeprazole/Naproxen? We can find it.
Rilpivirine (Complera, Edurant, Odefsey)
majorAbsolutely contraindicated. Esomeprazole raises gastric pH, dramatically reducing rilpivirine absorption. May cause HIV treatment failure and resistance.
Warfarin and oral anticoagulants
majorNSAIDs significantly increase bleeding risk when combined with anticoagulants. Avoid combination or monitor INR very closely.
Clopidogrel (Plavix)
majorEsomeprazole inhibits CYP2C19, reducing clopidogrel's active metabolite and potentially diminishing its antiplatelet effect.
Methotrexate
majorNSAIDs may reduce methotrexate renal clearance, increasing plasma levels and toxicity risk. Monitor closely.
Lithium
majorNSAIDs reduce renal prostaglandin synthesis, decreasing lithium excretion and potentially raising serum lithium to toxic levels.
ACE inhibitors and ARBs
moderateNSAIDs can blunt antihypertensive effect and increase risk of renal impairment. Monitor blood pressure and renal function.
SSRIs and SNRIs
moderateCombining NSAIDs with serotonin-affecting antidepressants increases GI bleeding risk. Monitor for signs of bleeding.
St. John's Wort
moderateCYP3A4/CYP2C19 inducer; significantly reduces esomeprazole plasma levels, potentially reducing stomach protection.
Esomeprazole/naproxen (generic Vimovo) remains a clinically valuable option for arthritis patients who need long-term NSAID therapy but are at elevated risk for stomach ulcers. The sequential-release pharmacokinetic design—esomeprazole first, then delayed naproxen—provides a level of stomach protection that cannot be replicated by taking the two drugs separately. With the brand-name Vimovo discontinued, patients and providers must navigate a generic market with uneven pharmacy stocking.
The biggest challenges patients face in 2026 are pharmacy availability and cost. Generic pricing at list can exceed $2,300 for 60 tablets, though GoodRx coupons can reduce this to approximately $119. Many insurance plans require prior authorization. When availability is a persistent issue, clinically appropriate alternatives include celecoxib, Arthrotec, or meloxicam plus an OTC PPI.
If you're struggling to find esomeprazole/naproxen at your local pharmacy, medfinder can search pharmacies in your area and text you the results—saving you the frustration of calling around yourself. medfinder covers all medications and all locations, making it the fastest way to locate hard-to-find prescriptions near you.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
Real-time availability
Medfinder is actively checking pharmacy inventory for Esomeprazole/Naproxen. We don't publish a number until we have enough verified pharmacy checks to be accurate — start a search and our team confirms current availability near you, usually within 24 hours.
ChatGPT
Claude
Gemini